Retinoid X receptor-interacting polypeptides and related molecules and methods
AssigneeThe General Hospital Corporation
InventorsDavid Moore, Wongi Seol, Hueng-Sik Choi
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsDavid Moore, Wongi Seol, Hueng-Sik Choi
Estimating the term…
Disclosed is a method for determining whether a test protein is capable of interacting with a retinoid X receptor protein. The method involves: (a) providing a host cell which contains (i) a reporter gene operably linked to a protein binding site; (ii) a first fusion gene which expresses a first fusion protein, the first fusion protein including a retinoid X receptor protein covalently bonded to a binding moiety which is capable of specifically binding to the protein binding site; and (iii) a second fusion gene which expresses a second fusion protein, the second fusion protein including the test protein covalently bonded to a gene activating moiety; and (b) determining whether the test protein increases expression of the reporter gene as an indication of its ability to interact with the retinoid X receptor protein. Also disclosed is purified DNA encoding retinoid X receptor-interacting proteins and the polypeptides expressed from such DNA.
A substantially pure RXR-interacting protein, comprising an amino acid sequence that is at least 85% identical to the amino acid sequence of RIP15 (SEQ ID NO:
RXR-interacting protein produced by expression of a purified DNA encoding a protein comprising an amino acid sequence that is at least 85% identical to the amino acid sequence of RIP15 (SEQ ID NO:
Dependencies are inferred from the claim text.